Niall O’Connor

A technology leader in the healthcare and life sciences spaces, Niall most recently acted as Chief Technology Officer for Genospace, a cloud-based software company focused on delivering personalized medicine. Niall was a member of the founding team at Genospace which was acquired by Sarah Cannon, the Cancer Institute of HCA. Niall also held software engineering positions at Dana-Farber Cancer Institute and Fidelity Investments.

Niall earned a B.S. in Electronics and Computers from National University of Ireland, Galway and attended the Executive Education Program at the Wharton School of University of Pennsylvania.